In CD5+ DLBCL, the distinct GO components of biological processes were “response to interleukin-7” and “regulation of cyclin-dependent protein kinase activity” (Figure 3A); the distinct GO components of cellular components were “chromosomal region,” “condensed nuclear chromosome,” and “nuclear matrix” (Figure 3B); and the distinct molecular functions were “kinase regulator activity,” “cyclin-dependent protein serine/threonine kinase regulator activity,” and “mismatch repair complex binding” (Figure 3C). The gene discussed is IL7; the disease is diffuse large B-cell lymphoma.